Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.69
-0.06 (-0.69%)
At close: Apr 28, 2026, 4:00 PM EDT
8.70
+0.01 (0.12%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $230.21 million as of April 28, 2026. Its market cap has increased by 18.43% in one year.
Market Cap
230.21M
Enterprise Value
198.58M
1-Year Change
18.43%
Ranking
Category
Stock Price
$8.69
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $230.21M, an increase of 296.88%. That is a compound annual growth rate of 38.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 230.21M | 19.04% |
| Dec 31, 2025 | 193.39M | 85.02% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adagene | 233.24M |
| Sol-Gel Technologies | 231.82M |
| Fennec Pharmaceuticals | 230.98M |
| Context Therapeutics | 230.62M |
| Heron Therapeutics | 228.25M |
| Orchestra BioMed Holdings | 228.23M |
| Achieve Life Sciences | 227.33M |
| Milestone Pharmaceuticals | 226.90M |